Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Debiopharm Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Debiopharm Group, Medical Devices Deals, 2012 to YTD 2018 9
Debiopharm Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Debiopharm Group, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Debiopharm Acquires Antibody Drug Candidate from ImmunoGen 13
Debiopharm International Acquires FibroTrap Sample Processing Technology from Spinomix 14
Debiopharm Group Acquires Antibiotic Clinical Assets and Technology Platform From Affinium 15
Venture Financing 17
ABAC Therapeutics Raises USD20 Million in Series A Financing 17
Immunexpress Raises US$6 Million In Venture Financing 19
Biocartis Raises US$40.5 Million In Series E Financing 20
Spinomix Raises US$3 Million In Series A Financing 22
Biocartis Raises US$44.7 Million In Series D Financing 23
Partnerships 25
Debiopharm Enters into Enters into Agreement with Paul Scherrer Institute 25
Debiopharm Partners with Merck and Pfizer 26
Debiopharm Enters into Distribution Agreement with Arbor Pharma 27
Debiopharm International Enters into Agreement with EORTC 28
United Labs Enters into Distribution Agreement with Debiopharm International 29
Debiopharm Enters into Agreement with Solid Biosciences 30
Debiopharm Enters into Co-Development Agreement with Nobelex Biotech 31
Atheris Labs Enters Into Agreement With Debiopharm For Debio 0826 Optimization 32
Experimental Therapeutics And Debiopharm Enter Into Agreement To Develop Epigenetic Oncology Target 33
Debiopharm International And TCG Lifesciences Enter Into Research Agreement To Develop Antibiotics 34
Cenix BioScience And Debiopharm Enter Into Agreement To Develop Drug Candidates 35
Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 36
Licensing Agreements 37
Debiopharm International Enters into Licensing Agreement with Almac Discovery 37
Evotec Enters Into Licensing Agreement With Debiopharm 38
Chugai Pharma Enters Into Licensing Agreement With Debiopharm Group For FF284 39
Debiopharm Enters Into Licensing Agreement With Yale University 40
Shasun Pharma Enters Into Licensing Agreement With Debiopharm 41
Debiopharm Enters Into Licensing Agreement With Ascepion Pharma For Kinase Inhibitor, ASP-08126 42
Acquisition 43
Debiopharm To Acquire Pharma Company 43
Debiopharm Group – Key Competitors 44
Debiopharm Group – Key Employees 45
Debiopharm Group – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Debiopharm Group, Pharmaceuticals & Healthcare, Key Facts 2
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Debiopharm Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Debiopharm Group, Deals By Therapy Area, 2012 to YTD 2018 8
Debiopharm Group, Medical Devices Deals, 2012 to YTD 2018 9
Debiopharm Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Debiopharm Acquires Antibody Drug Candidate from ImmunoGen 13
Debiopharm International Acquires FibroTrap Sample Processing Technology from Spinomix 14
Debiopharm Group Acquires Antibiotic Clinical Assets and Technology Platform From Affinium 15
ABAC Therapeutics Raises USD20 Million in Series A Financing 17
Immunexpress Raises US$6 Million In Venture Financing 19
Biocartis Raises US$40.5 Million In Series E Financing 20
Spinomix Raises US$3 Million In Series A Financing 22
Biocartis Raises US$44.7 Million In Series D Financing 23
Debiopharm Enters into Enters into Agreement with Paul Scherrer Institute 25
Debiopharm Partners with Merck and Pfizer 26
Debiopharm Enters into Distribution Agreement with Arbor Pharma 27
Debiopharm International Enters into Agreement with EORTC 28
United Labs Enters into Distribution Agreement with Debiopharm International 29
Debiopharm Enters into Agreement with Solid Biosciences 30
Debiopharm Enters into Co-Development Agreement with Nobelex Biotech 31
Atheris Labs Enters Into Agreement With Debiopharm For Debio 0826 Optimization 32
Experimental Therapeutics And Debiopharm Enter Into Agreement To Develop Epigenetic Oncology Target 33
Debiopharm International And TCG Lifesciences Enter Into Research Agreement To Develop Antibiotics 34
Cenix BioScience And Debiopharm Enter Into Agreement To Develop Drug Candidates 35
Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 36
Debiopharm International Enters into Licensing Agreement with Almac Discovery 37
Evotec Enters Into Licensing Agreement With Debiopharm 38
Chugai Pharma Enters Into Licensing Agreement With Debiopharm Group For FF284 39
Debiopharm Enters Into Licensing Agreement With Yale University 40
Shasun Pharma Enters Into Licensing Agreement With Debiopharm 41
Debiopharm Enters Into Licensing Agreement With Ascepion Pharma For Kinase Inhibitor, ASP-08126 42
Debiopharm To Acquire Pharma Company 43
Debiopharm Group, Key Competitors 44
Debiopharm Group, Key Employees 45
Debiopharm Group, Subsidiaries 46
List of Figures
Debiopharm Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Debiopharm Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Debiopharm Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Debiopharm Group, Medical Devices Deals, 2012 to YTD 2018 9